Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma.
Kai-Cai LiuWei-Fu LvDong LuChang-Long HouJun XieYu-He LuQi-Sheng CaoYu-Lin TanYing-Zhan ZhangJie LiuPublished in: Cancer management and research (2021)
DEB-TACE has potential efficacy and safety after failure of c-TACE in patients with advanced liver cancer. Further studies are needed to confirm the efficacy of DEB-TACE treatment after failure of c-TACE.